Richard Peterson

2017 - Sienna Biopharmaceuticals

In 2017, Richard Peterson earned a total compensation of $1.4M as Chief Financial Officer at Sienna Biopharmaceuticals.

Compensation breakdown

Bonus$25,000
Non-Equity Incentive Plan$120,827
Option Awards$998,529
Salary$258,229
Other$35,309
Total$1,437,894

Peterson received $998.5K in option awards, accounting for 69% of the total pay in 2017.

Peterson also received $25K in bonus, $120.8K in non-equity incentive plan, $258.2K in salary and $35.3K in other compensation.

Rankings

In 2017, Richard Peterson's compensation ranked 7,209th out of 14,666 executives tracked by ExecPay. In other words, Peterson earned more than 50.8% of executives.

ClassificationRankingPercentile
All
7,209
out of 14,666
51st
Division
Manufacturing
2,682
out of 5,772
54th
Major group
Chemicals And Allied Products
877
out of 2,075
58th
Industry group
Drugs
685
out of 1,731
60th
Industry
Pharmaceutical Preparations
538
out of 1,333
60th
Source: SEC filing on April 19, 2018.

Peterson's colleagues

We found four more compensation records of executives who worked with Richard Peterson at Sienna Biopharmaceuticals in 2017.

2017

Frederick Beddingfield

Sienna Biopharmaceuticals

Chief Executive Officer

2017

Todd Harris

Sienna Biopharmaceuticals

Head of Corporate Development

2017

Timothy Andrews

Sienna Biopharmaceuticals

General Counsel

2017

John Smither

Sienna Biopharmaceuticals

Chief Financial Officer

In-depth

You may also like